Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aharon Lubetsky

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Postgraduate Medical Journal|June 28, 2025
Anticoagulation discharge treatment recommendations in patients admitted with a first-time diagnosis of atrial fibrillationOrly Efros, Gili Kenet, Aharon Lubetsky, et al.
Blood|November 18, 2006
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistanceRonen Loebstein, Ilana Dvoskin, Hillel Halkin, et al.
Pediatric Blood & Cancer|March 11, 2024
Pediatric splenic infarction: Assessment of associated clinical conditions and outcomeEvgeny Grishin, Michalle Soudack, Sarina Levy-Mendelovich, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 27, 2021
Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and managementKeren Rosen, Ehud Raanani, Alexander Kogan, et al.
Pediatric Blood & Cancer|August 23, 2022
Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin-induced thrombocytopeniaOmri Cohen, Kfir Lange, Ivan Budnik, et al.
Pediatric Blood & Cancer|November 25, 2024
The Impact of Emicizumab Prophylaxis on Hospitalizations and Emergency Department Visits Among Hemophilia A Patients Is Age RelatedDan Geller, Ivan Budnik, Tlalit Barhod, et al.
Blood Cells, Molecules & Diseases|December 19, 2020
The potential role of emicizumab prophylaxis in severe von Willebrand diseaseAssaf A Barg, Einat Avishai, Ivan Budnik, et al.
RMD Open|August 27, 2025
Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysisAya Berman, Gili Kenet, Aharon Lubetsky, et al.
Thrombosis and Haemostasis|October 7, 2004
Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled studyGili Kenet, Dalia Waldman, Aharon Lubetsky, et al.
Research and Practice in Thrombosis and Haemostasis|October 25, 2023
Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment centerOmri Cohen, Sarina Levy-Mendelovich, Ivan Budnik, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Postgraduate Medical Journal|June 28, 2025
Anticoagulation discharge treatment recommendations in patients admitted with a first-time diagnosis of atrial fibrillationOrly Efros, Gili Kenet, Aharon Lubetsky, et al.
Blood|November 18, 2006
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistanceRonen Loebstein, Ilana Dvoskin, Hillel Halkin, et al.
Pediatric Blood & Cancer|March 11, 2024
Pediatric splenic infarction: Assessment of associated clinical conditions and outcomeEvgeny Grishin, Michalle Soudack, Sarina Levy-Mendelovich, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 27, 2021
Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and managementKeren Rosen, Ehud Raanani, Alexander Kogan, et al.
Pediatric Blood & Cancer|August 23, 2022
Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin-induced thrombocytopeniaOmri Cohen, Kfir Lange, Ivan Budnik, et al.
Pediatric Blood & Cancer|November 25, 2024
The Impact of Emicizumab Prophylaxis on Hospitalizations and Emergency Department Visits Among Hemophilia A Patients Is Age RelatedDan Geller, Ivan Budnik, Tlalit Barhod, et al.
Blood Cells, Molecules & Diseases|December 19, 2020
The potential role of emicizumab prophylaxis in severe von Willebrand diseaseAssaf A Barg, Einat Avishai, Ivan Budnik, et al.
RMD Open|August 27, 2025
Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysisAya Berman, Gili Kenet, Aharon Lubetsky, et al.
Thrombosis and Haemostasis|October 7, 2004
Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled studyGili Kenet, Dalia Waldman, Aharon Lubetsky, et al.
Research and Practice in Thrombosis and Haemostasis|October 25, 2023
Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment centerOmri Cohen, Sarina Levy-Mendelovich, Ivan Budnik, et al.
Pageof 5